2022
DOI: 10.1155/2022/6971238
|View full text |Cite
|
Sign up to set email alerts
|

Weighted Gene Coexpression Network Analysis Identifies Crucial Genes Involved in Coronary Atherosclerotic Heart Disease

Abstract: Background. Coronary atherosclerotic heart disease (CHD) is a lethal disease with an unstated pathogenic mechanism. Therefore, it is urgent to develop innovative strategies to ameliorate the outcome of CHD patients and explore novel biomarkers connected to the pathogenicity of CHD. Methods. The weighted gene coexpression network analysis (WGCNA) was carried out on a coronary atherosclerosis dataset GSE90074 to determine the crucial modules and hub genes for their prospective relationship to CHD. After the diff… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 49 publications
0
0
0
Order By: Relevance
“…Coronary artery disease (CAD) is a complex and multifactorial condition that involves various pathways such as inflammation, oxidative stress, myocardial injury, apoptosis, neurohormonal activation, and hemodynamic stress [ 1 ]. Biomarkers that reflect these pathways can help in the diagnosis, management, and prognosis of CAD and its complications [ 1 ]. The discovery of new biomarkers can also improve the clinical decision-making process and provide new insights into the pathophysiology and prevention of CAD [ 2 ].…”
Section: Introductionmentioning
confidence: 99%
“…Coronary artery disease (CAD) is a complex and multifactorial condition that involves various pathways such as inflammation, oxidative stress, myocardial injury, apoptosis, neurohormonal activation, and hemodynamic stress [ 1 ]. Biomarkers that reflect these pathways can help in the diagnosis, management, and prognosis of CAD and its complications [ 1 ]. The discovery of new biomarkers can also improve the clinical decision-making process and provide new insights into the pathophysiology and prevention of CAD [ 2 ].…”
Section: Introductionmentioning
confidence: 99%